[Clinical experience with ampicillin-cloxacillin (Rectocillin 'Kyowa') in uroloigcal field (author's transl)].
Ampicillin-cloxacillin (Rectocillin 'Kyowa') was administered either orally (capsules) or by intravenous drip infusion to a total of 40 patients and the following results were obtained: 1. Effectiveness obtained in the group received Rectocillin capsules (1,500 mg/day) was 80%. 2. Effectiveness obtained in the group received Rectocillin intravenous drip infusion (3 similar to 10 g/day) was 64.7%. 3. Side effects were encountered in 2 of 40 patients, but none of them were serious, and clinical abnormalities due to this antibiotic were not observed.
D000208:Acute Disease; D000284:Administration, Oral; D000328:Adult; D000667:Ampicillin / Q000008:administration & dosage* / Q000627:therapeutic use; D002214:Capsules; D002908:Chronic Disease; D003023:Cloxacillin / Q000008:administration & dosage* / Q000627:therapeutic use; D003556:Cystitis / Q000188:drug therapy; D004338:Drug Combinations; D004341:Drug Evaluation; D004823:Epididymitis / Q000188:drug therapy; D005260:Female; D006801:Humans; D007263:Infusions, Parenteral; D008297:Male; D008875:Middle Aged; D011472:Prostatitis / Q000188:drug therapy; D011702:Pyelitis / Q000188:drug therapy; D013530:Surgical Wound Infection / Q000517:prevention & control; D014526:Urethritis / Q000188:drug therapy; D014570:Urologic Diseases / Q000188:drug therapy*
D002214:Capsules; D004338:Drug Combinations; D000667:Ampicillin; D003023:Cloxacillin